Published in Antimicrob Agents Chemother on December 01, 2002
H pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut (2004) 4.66
Helicobacter pylori detection and antimicrobial susceptibility testing. Clin Microbiol Rev (2007) 3.43
Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world? Clin Microbiol Rev (2013) 2.01
Helicobacter acinonychis: genetic and rodent infection studies of a Helicobacter pylori-like gastric pathogen of cheetahs and other big cats. J Bacteriol (2004) 1.35
Cluster of type IV secretion genes in Helicobacter pylori's plasticity zone. J Bacteriol (2003) 1.26
Fitness cost due to mutations in the 16S rRNA associated with spectinomycin resistance in Chlamydia psittaci 6BC. Antimicrob Agents Chemother (2005) 1.24
Frequency of spontaneous mutations that confer antibiotic resistance in Chlamydia spp. Antimicrob Agents Chemother (2005) 1.21
Effects of 16S rRNA gene mutations on tetracycline resistance in Helicobacter pylori. Antimicrob Agents Chemother (2003) 1.13
Antimicrobial susceptibility and resistance patterns among Helicobacter pylori strains from The Gambia, West Africa. Antimicrob Agents Chemother (2012) 0.93
Who's Winning the War? Molecular Mechanisms of Antibiotic Resistance in Helicobacter pylori. Curr Drug ther (2008) 0.92
Evaluation of seaFAST, a rapid fluorescent in situ hybridization test, for detection of Helicobacter pylori and resistance to clarithromycin in paraffin-embedded biopsy sections. J Clin Microbiol (2005) 0.90
The Helicobacter pylori flaA1 and wbpB genes control lipopolysaccharide and flagellum synthesis and function. J Bacteriol (2004) 0.90
Identification and role of functionally important motifs in the 970 loop of Escherichia coli 16S ribosomal RNA. J Mol Biol (2007) 0.90
Negamycin interferes with decoding and translocation by simultaneous interaction with rRNA and tRNA. Mol Cell (2014) 0.89
Age-dependent changes in susceptibility of suckling mice to individual strains of Helicobacter pylori. Infect Immun (2005) 0.87
Tetracycline-resistant clinical Helicobacter pylori isolates with and without mutations in 16S rRNA-encoding genes. Antimicrob Agents Chemother (2005) 0.87
Real-time PCR screening for 16S rRNA mutations associated with resistance to tetracycline in Helicobacter pylori. Antimicrob Agents Chemother (2005) 0.85
16S rRNA mutations that confer tetracycline resistance in Helicobacter pylori decrease drug binding in Escherichia coli ribosomes. J Bacteriol (2005) 0.85
Molecular characterization of benzimidazole resistance in Helicobacter pylori. Antimicrob Agents Chemother (2004) 0.83
16S rRNA gene mutations associated with decreased susceptibility to tetracycline in Mycoplasma bovis. Antimicrob Agents Chemother (2014) 0.81
Absence of Helicobacter pylori high tetracycline resistant 16S rDNA AGA926-928TTC genotype in gastric biopsy specimens from dyspeptic patients of a city in the interior of São Paulo, Brazil. BMC Gastroenterol (2012) 0.78
Tetracyclines in malaria. Malar J (2015) 0.77
Multiple mutations and increased RNA expression in tetracycline-resistant Streptococcus pneumoniae as determined by genome-wide DNA and mRNA sequencing. J Antimicrob Chemother (2015) 0.77
Evolutionary and sequence-based relationships in bacterial AdoMet-dependent non-coding RNA methyltransferases. BMC Res Notes (2014) 0.76
Resistance mutations generate divergent antibiotic susceptibility profiles against translation inhibitors. Proc Natl Acad Sci U S A (2016) 0.75
rRNA Binding Sites and the Molecular Mechanism of Action of the Tetracyclines. Antimicrob Agents Chemother (2016) 0.75
Julian Davies and the discovery of kanamycin resistance transposon Tn5. J Antibiot (Tokyo) (2016) 0.75
Absence of association between Plasmodium falciparum small sub-unit ribosomal RNA gene mutations and in vitro decreased susceptibility to doxycycline. Malar J (2015) 0.75
The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature (1997) 34.00
Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev (2001) 9.14
Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther (2002) 6.17
The biological cost of antibiotic resistance. Curr Opin Microbiol (1999) 6.08
Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob Agents Chemother (1996) 6.01
Active efflux mechanisms for antimicrobial resistance. Antimicrob Agents Chemother (1992) 4.82
The structural basis for the action of the antibiotics tetracycline, pactamycin, and hygromycin B on the 30S ribosomal subunit. Cell (2000) 4.82
Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation. Science (2002) 4.38
Multidrug resistance mechanisms: drug efflux across two membranes. Mol Microbiol (2000) 3.71
Crystal structures of complexes of the small ribosomal subunit with tetracycline, edeine and IF3. EMBO J (2001) 3.68
Evolution by small steps and rugged landscapes in the RNA virus phi6. Genetics (1999) 3.58
Differences in genotypes of Helicobacter pylori from different human populations. J Bacteriol (2000) 3.39
Comparative genomics of Helicobacter pylori: analysis of the outer membrane protein families. Infect Immun (2000) 3.13
Distinctiveness of genotypes of Helicobacter pylori in Calcutta, India. J Bacteriol (2000) 2.81
Macrolide resistance in Helicobacter pylori: mechanism and stability in strains from clarithromycin-treated patients. Antimicrob Agents Chemother (1997) 2.73
Preventing drug access to targets: cell surface permeability barriers and active efflux in bacteria. Semin Cell Dev Biol (2001) 2.47
Point mutations in the 23S rRNA gene of Helicobacter pylori associated with different levels of clarithromycin resistance. J Antimicrob Chemother (1997) 2.47
Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia. Br J Dermatol (2001) 2.14
Molecular epidemiology of Helicobacter pylori: separation of H. pylori from East Asian and non-Asian countries. Epidemiol Infect (2000) 1.97
Host specificity of Helicobacter pylori strains and host responses in experimentally challenged nonhuman primates. Gastroenterology (1999) 1.96
16S rRNA mutation associated with tetracycline resistance in a gram-positive bacterium. Antimicrob Agents Chemother (1998) 1.94
Enzymes associated with reductive activation and action of nitazoxanide, nitrofurans, and metronidazole in Helicobacter pylori. Antimicrob Agents Chemother (2002) 1.84
Metronidazole activation is mutagenic and causes DNA fragmentation in Helicobacter pylori and in Escherichia coli containing a cloned H. pylori RdxA(+) (Nitroreductase) gene. J Bacteriol (2000) 1.83
Sequential inactivation of rdxA (HP0954) and frxA (HP0642) nitroreductase genes causes moderate and high-level metronidazole resistance in Helicobacter pylori. J Bacteriol (2000) 1.77
Site-specific mutations in the 23S rRNA gene of Helicobacter pylori confer two types of resistance to macrolide-lincosamide-streptogramin B antibiotics. Antimicrob Agents Chemother (1998) 1.76
Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovafloxacin in The Netherlands. J Antimicrob Chemother (1999) 1.73
Mutations in the 16S rRNA genes of Helicobacter pylori mediate resistance to tetracycline. J Bacteriol (2002) 1.70
Pattern of primary resistance of Helicobacter pylori to metronidazole or clarithromycin in the United States. Arch Intern Med (2001) 1.66
Helicobacter pylori uptake and efflux: basis for intrinsic susceptibility to antibiotics in vitro. Antimicrob Agents Chemother (2000) 1.58
Features and trends in Helicobacter pylori antibiotic resistance in Lisbon area, Portugal (1990-1999). J Antimicrob Chemother (2000) 1.54
Resistance of helicobacter pylori to metronidazole, tetracycline and amoxycillin. J Antimicrob Chemother (2000) 1.44
Roles of FrxA and RdxA nitroreductases of Helicobacter pylori in susceptibility and resistance to metronidazole. J Bacteriol (2001) 1.39
Sources of variation of Helicobacter pylori treatment success in adults worldwide: a meta-analysis. Int J Epidemiol (2002) 1.34
A soxRS-constitutive mutation contributing to antibiotic resistance in a clinical isolate of Salmonella enterica (Serovar typhimurium). Antimicrob Agents Chemother (2001) 1.28
Primary and combined resistance to four antimicrobial agents in Helicobacter pylori in Sofia, Bulgaria. J Med Microbiol (2000) 1.27
Characterization of two cryptic Helicobacter pylori plasmids: a putative source for horizontal gene transfer and gene shuffling. J Bacteriol (2002) 1.23
Isolation and characterization of tetracycline-resistant clinical isolates of Helicobacter pylori. Antimicrob Agents Chemother (2000) 1.19
Helicobacter pylori therapy: first-line options and rescue regimen. Dig Dis (2001) 1.08
Evolution of metronidazole and tetracycline susceptibility pattern in Helicobacter pylori at a hospital in Saudi Arabia. Int J Antimicrob Agents (2001) 0.98
Activity of antibiotics and azole antimycotics against Helicobacter pylori. Zentralbl Bakteriol (1993) 0.92
Nucleotide sequence and characterization of cdrA, a cell division-related gene of Helicobacter pylori. J Bacteriol (1998) 0.92
Comparison of culture, histopathology and urease testing for the diagnosis of Helicobacter pylori gastritis and susceptibility to amoxycillin, clarithromycin, metronidazole and tetracycline. Pathology (1998) 0.86
Antibiotic resistance and antibiotic sensitivity based treatment in Helicobacter pylori infection: advantages and outcome. Arch Dis Child (2001) 0.86
[Evolution of the sensitivity of 235 strains of Helicobacter pylori from 1995 to 1998 and impact of antibiotic treatment]. Enferm Infecc Microbiol Clin (2002) 0.85
In vitro synergy between ranitidine bismuth citrate and tetracycline or clarithromycin against resistant strains of Helicobacter pylori. Eur J Clin Microbiol Infect Dis (1999) 0.82
[Antibiotic resistance among strains of Helicobacter pylori in Gothenburg. Bacteria resistant to metronidazole]. Lakartidningen (1998) 0.79
[Helicobacter pylori: pretherapeutic resistance status in Germany (Ruhr area)]. Z Gastroenterol (1997) 0.78
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature (2012) 16.13
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet (2011) 7.98
Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation. Science (2002) 4.38
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis. J Crohns Colitis (2010) 3.97
Mutation discovery in bacterial genomes: metronidazole resistance in Helicobacter pylori. Nat Methods (2005) 3.19
Functional adaptation of BabA, the H. pylori ABO blood group antigen binding adhesin. Science (2004) 3.06
Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis. Gastroenterology (2011) 2.52
Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study. Lancet Infect Dis (2012) 2.18
Helicobacter pylori CagA phosphorylation-independent function in epithelial proliferation and inflammation. Cell Host Microbe (2009) 1.96
Enzymes associated with reductive activation and action of nitazoxanide, nitrofurans, and metronidazole in Helicobacter pylori. Antimicrob Agents Chemother (2002) 1.84
Association between variants of PRDM1 and NDP52 and Crohn's disease, based on exome sequencing and functional studies. Gastroenterology (2013) 1.83
Genome-wide association study for ulcerative colitis identifies risk loci at 7q22 and 22q13 (IL17REL). Nat Genet (2010) 1.72
Metastability of Helicobacter pylori bab adhesin genes and dynamics in Lewis b antigen binding. Proc Natl Acad Sci U S A (2004) 1.71
Transposable element ISHp608 of Helicobacter pylori: nonrandom geographic distribution, functional organization, and insertion specificity. J Bacteriol (2002) 1.60
Susceptibilities to telithromycin and six other agents and prevalence of macrolide resistance due to L4 ribosomal protein mutation among 992 Pneumococci from 10 central and Eastern European countries. Antimicrob Agents Chemother (2002) 1.56
Helicobacter pylori tissue tropism: mouse-colonizing strains can target different gastric niches. Microbiology (2003) 1.55
Classical ctxB in Vibrio cholerae O1, Kolkata, India. Emerg Infect Dis (2009) 1.53
Evaluation of a rapid immunochromatographic dipstick kit for diagnosis of cholera emphasizes its outbreak utility. Jpn J Infect Dis (2010) 1.52
Revised nomenclature for transposable genetic elements. Plasmid (2008) 1.50
Helicobacter Pylori's plasticity zones are novel transposable elements. PLoS One (2009) 1.48
Helicobacter pylori from Peruvian amerindians: traces of human migrations in strains from remote Amazon, and genome sequence of an Amerind strain. PLoS One (2010) 1.48
Antimicrobial activity of curcumin against Helicobacter pylori isolates from India and during infections in mice. Antimicrob Agents Chemother (2009) 1.45
Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study. Gut (2013) 1.37
Helicobacter acinonychis: genetic and rodent infection studies of a Helicobacter pylori-like gastric pathogen of cheetahs and other big cats. J Bacteriol (2004) 1.35
Adherent and invasive Escherichia coli is associated with granulomatous colitis in boxer dogs. Infect Immun (2006) 1.26
Cluster of type IV secretion genes in Helicobacter pylori's plasticity zone. J Bacteriol (2003) 1.26
Expression of the BabA adhesin during experimental infection with Helicobacter pylori. Infect Immun (2010) 1.26
Helicobacter pylori reinfection is common in Peruvian adults after antibiotic eradication therapy. J Infect Dis (2003) 1.21
A worldwide analysis of beta-defensin copy number variation suggests recent selection of a high-expressing DEFB103 gene copy in East Asia. Hum Mutat (2011) 1.21
Contraselectable streptomycin susceptibility determinant for genetic manipulation and analysis of Helicobacter pylori. Appl Environ Microbiol (2006) 1.20
Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers. Scand J Gastroenterol (2012) 1.18
DNA-level characterization of Helicobacter pylori strains from patients with overt disease and with benign infections in Bangladesh. J Clin Microbiol (2003) 1.18
Virulence genes in Helicobacter pylori strains from West Bengal residents with overt H. pylori-associated disease and healthy volunteers. J Clin Microbiol (2002) 1.17
Presence of active aliphatic amidases in Helicobacter species able to colonize the stomach. Infect Immun (2003) 1.15
Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy. Gastroenterology (2005) 1.15
Motility of urease-deficient derivatives of Helicobacter pylori. J Bacteriol (2004) 1.14
Development and evaluation of a PCR assay for tracking the emergence and dissemination of Haitian variant ctxB in Vibrio cholerae O1 strains isolated from Kolkata, India. J Clin Microbiol (2012) 1.13
Helicobacter pylori adhesion to carbohydrates. Methods Enzymol (2006) 1.12
Susceptibility to telithromycin in 1,011 Streptococcus pyogenes isolates from 10 central and Eastern European countries. Antimicrob Agents Chemother (2002) 1.12
Diverse phenotypes resulting from polyphosphate kinase gene (ppk1) inactivation in different strains of Helicobacter pylori. J Bacteriol (2005) 1.11
Multiplex PCR assay for rapid detection and genotyping of Helicobacter pylori directly from biopsy specimens. J Clin Microbiol (2004) 1.07
Attenuated CagA oncoprotein in Helicobacter pylori from Amerindians in Peruvian Amazon. J Biol Chem (2011) 1.06
Species-specific identification of Vibrio fluvialis by PCR targeted to the conserved transcriptional activation and variable membrane tether regions of the toxR gene. J Med Microbiol (2006) 1.06
Gastrin-mediated interleukin-8 and cyclooxygenase-2 gene expression: differential transcriptional and posttranscriptional mechanisms. Gastroenterology (2008) 1.05
Vibrio cholerae O1 clinical strains isolated in 1992 in Kolkata with progenitor traits of the 2004 Mozambique variant. J Med Microbiol (2009) 1.04
Antimicrobial susceptibility of Helicobacter pylori strains isolated in Bangladesh. J Clin Microbiol (2004) 1.03
Virulence genes and neutral DNA markers of Helicobacter pylori isolates from different ethnic communities of West Bengal, India. J Clin Microbiol (2003) 1.02
Quantitative evaluation of inflammatory and immune responses in the early stages of chronic Helicobacter pylori infection. Infect Immun (2003) 1.02
Intrahepatic cholestasis of pregnancy-current achievements and unsolved problems. World J Gastroenterol (2008) 1.01
The fdxA ferredoxin gene can down-regulate frxA nitroreductase gene expression and is essential in many strains of Helicobacter pylori. J Bacteriol (2003) 1.01
Multiple infection and microdiversity among Helicobacter pylori isolates in a single host in India. PLoS One (2012) 1.01
Helicobacter pylori evolution: lineage- specific adaptations in homologs of eukaryotic Sel1-like genes. PLoS Comput Biol (2007) 0.99
Cag pathogenicity island-independent up-regulation of matrix metalloproteinases-9 and -2 secretion and expression in mice by Helicobacter pylori infection. J Biol Chem (2006) 0.98
Alaska sentinel surveillance for antimicrobial resistance in Helicobacter pylori isolates from Alaska native persons, 1999-2003. Helicobacter (2006) 0.98
Novel 180- and 480-base-pair insertions in African and African-American strains of Helicobacter pylori. J Clin Microbiol (2004) 0.98
Vibrio cholerae non-O1, non-O139 serogroups and cholera-like diarrhea, Kolkata, India. Emerg Infect Dis (2013) 0.98
Quantitative effect of luxS gene inactivation on the fitness of Helicobacter pylori. Appl Environ Microbiol (2006) 0.97
Validation of string test for diagnosis of Helicobacter pylori infections. J Clin Microbiol (2006) 0.97
Sequence organization and insertion specificity of the novel chimeric ISHp609 transposable element of Helicobacter pylori. J Bacteriol (2004) 0.96
The validity of a biomarker method for indirect detection of gastric mucosal atrophy versus standard histopathology. Dig Dis Sci (2009) 0.96
Host Lewis phenotype-dependent Helicobacter pylori Lewis antigen expression in rhesus monkeys. FASEB J (2006) 0.95
Point mutations in Helicobacter pylori's fur regulatory gene that alter resistance to metronidazole, a prodrug activated by chemical reduction. PLoS One (2011) 0.94
The secreted Helicobacter cysteine-rich protein A causes adherence of human monocytes and differentiation into a macrophage-like phenotype. FEBS Lett (2009) 0.94
Evolutionary dynamics of insertion sequences in Helicobacter pylori. J Bacteriol (2004) 0.93
Antimicrobial susceptibility and resistance patterns among Helicobacter pylori strains from The Gambia, West Africa. Antimicrob Agents Chemother (2012) 0.93
Campylobacter jejuni in hospitalized patients with diarrhea, Kolkata, India. Emerg Infect Dis (2013) 0.93
DNA-level diversity and relatedness of Helicobacter pylori strains in shantytown families in Peru and transmission in a developing-country setting. J Clin Microbiol (2008) 0.93
Cytotoxic and cell vacuolating activity of Vibrio fluvialis isolated from paediatric patients with diarrhoea. J Med Microbiol (2005) 0.92
Haitian variant tcpA in Vibrio cholerae O1 El Tor strains in Kolkata, India. J Clin Microbiol (2013) 0.91
Genetic control of global gene expression levels in the intestinal mucosa: a human twin study. Physiol Genomics (2009) 0.91
Mechanism of drug resistance in clonally related clinical isolates of Vibrio fluvialis isolated in Kolkata, India. Antimicrob Agents Chemother (2006) 0.91
Socioeconomic and nutritional factors account for the association of gastric cancer with Amerindian ancestry in a Latin American admixed population. PLoS One (2012) 0.91
Evaluation of a novel 14C-urea breath test "Heliprobe" in diagnosis of Helicobacter pylori infection. Medicina (Kaunas) (2007) 0.90
Influence of wrap length on the effectiveness of Nissen and Toupet fundoplication: a prospective randomized study. Surg Endosc (2008) 0.90
Disease-specific health-related quality of life and its determinants in liver cirrhosis patients in Lithuania. World J Gastroenterol (2006) 0.90
Surface properties of Helicobacter pylori urease complex are essential for persistence. PLoS One (2010) 0.90
Evaluation of seaFAST, a rapid fluorescent in situ hybridization test, for detection of Helicobacter pylori and resistance to clarithromycin in paraffin-embedded biopsy sections. J Clin Microbiol (2005) 0.90